Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timentin via PILP for diabetic lower limb infection
NCT02158442Phase 2Completed
- Sponsor
- Osprey Medical
- Start
- Oct 2013
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Osprey Medical. Primary endpoint: Efficacy of Timentin Delivered by PILP Procedure Versus Intravenous Delivery at Reducing Microbiological Load at Day 3. Started Oct 2013; status: completed.
Beyond the preview
Go deeper on NCT02158442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158442.